Abstract:1 We studied the effect of temperature on the binding to rat heart M2 muscarinic receptors of antagonists related to the carbon/silicon pairs pridinol/sila‐pridinol and diphenidol/sila‐diphenidol (including three germanium compounds) and six structurally related pairs of enantiomers [(R)‐ and (S)‐procyclidine, (R)‐ and (S)‐trihexyphenidyl, (R)‐ and (S)‐tricyclamol, (R)‐ and (S)‐trihexyphenidyl methiodide, (R)‐ and (S)‐hexahydro‐diphenidol and (R)‐ and (S)‐hexbutinol]. Binding affinities were determined in competition experiments using [3H]‐N‐methyl‐scopolamine chloride as radioligand. The reference drugs were scopolamine and N‐methyl‐scopolamine bromide. 2 The affinity of the antagonists either increased or decreased with temperature, van 't Hoff plots were linear in the 278–310°K temperature range. Binding of all antagonists was entropy driven. Enthalpy changes varied from large negative values (down to −29 kJ mol−1) to large positive values (up to + 30 kJ mol−1). 3 (R)‐configurated drugs had a 10 to 100 fold greater affinity for M2 receptors than the corresponding (S)‐enantiomers. Enthalpy and entropy changes of the respective enantiomers were different but no consistent pattern was observed. 4 When silanols (R3SiOH) were compared to carbinols (R3COH), the affinity increase caused by C/Si exchange varied between 3 and 10 fold for achiral drugs but was negligible in the case of chiral drugs. Silanols induced more favourable enthalpy and less favourable entropy changes than the corresponding carbinols when binding. Organogermanium compounds (R4Ge) when compared to their silicon counterparts (R4Si) showed no significant difference in affinity as well as in enthalpy and entropy changes. 5 Exchange of a cyclohexyl by a phenyl moiety was associated with an increase or a decrease in drug affinity (depending on the absolute configuration in the case of chiral drugs) and generally also with a more favourable enthalpy change and a less favourable entropy change of drug binding. 6 Replacement of a pyrrolidino by a piperidino group and increasing the length of the alkylene chain bridging the amino group and the central carbon or silicon atom were associated with either an increase or a decrease of entropy and enthalpy changes of drug binding. However, there was no clear correlation between these structural variations and the thermodynamic effects. 7 Taken together, these results suggest that hydrogen bond‐forming OH groups and, to a lesser extent, polarizable phenyl groups contribute significantly to the thermodynamics of interactions between these classes of muscarinic antagonists and M2 muscarinic receptors.

New potent muscarinic receptor ligands bearing the 1,4‐dioxane nucleus: Investigation on the nature of the substituent in position 2

The Effect of Absolute Configuration on Activity, Subtype Selectivity (M3/M2) of 3Α-Acyloxy-6β-acetoxyltropane Derivatives As Muscarinic M3 Receptor Antagonists

The optimization of a novel selective antagonist for human M<sub>2</sub> muscarinic acetylcholine receptor

Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists

Chemistry And Pharmacological Characterization Of Novel Nitrogen Analogues Of Amop-H-Oh (Sazetidine-A, 6[5-(Azetidin-2-Ylmethoxy)Pyridin-3-Yl]Hex-5-Yn-L-Ol) As Alpha 4 Beta 2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists

Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

Biososteric Replacement in the Design and Synthesis of Ligands for Nicotinic Acetylcholine Receptors

The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs

Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila‐pridinol, diphenidol and sila‐diphenidol type

Design, synthesis and evaluation of novel 2-phenyl-3-(1 H -pyrazol-4-yl)pyridine positive allosteric modulators for the M 4 mAChR

Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.

Structure-based Discovery of Selective Positive Allosteric Modulators of Antagonists for the M2 Muscarinic Acetylcholine Receptor.

Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor

Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors

Investigation of muscarinic acetylcholine receptor M3 activation in atomistic detail: a chemist's viewpoint

Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.

The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents

Muscarinic Acetylcholine Receptor Modulators Derived from Natural Toxins and Diverse Interaction Modes

Recent Progress in Selective Muscarinic Agonists

Synthesis and Structure–activity Relationships of 5-Substituted Pyridine Analogues of 3-[2-((s)-pyrrolidinyl)methoxy]pyridine, A-84543: A Potent Nicotinic Receptor Ligand

Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.